+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07033715

Effects of a 12-week Exercise Intervention on Physical and Mental Health in Hereditary ATTR ATTRv Amyloidosis

Led by University of Maia · Updated on 2025-06-24

42

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are investigating the effects of a 12-week exercise program on both the physical and mental health of people living with Hereditary ATTR ATTRv Amyloidosis, a rare genetic disease caused by mutations in the transthyretin gene that lead to amyloid deposits in nerves and organs. This study seeks to expand knowledge in this area, especially among patients receiving new therapies, and aims to explore the potential mental health benefits of exercise alongside physical improvements. It also aims to raise awareness about the importance of an active lifestyle for improving quality of life in this community. Participants will be randomly assigned to one of two groups one group will take part in a supervised exercise program lasting 12 weeks, while the other group will not participate in the exercise intervention. The exercise program includes sessions three times a week, each lasting 60 minutes, with gradually increasing intensity monitored by a perceived exertion scale. Exercises focus on cardiorespiratory fitness, resistance training, flexibility, and neuromotor skills such as balance, coordination, and gait. Activities like tai ji and yoga are also included to support overall motor skills and joint mobility. Throughout the study, participants will undergo assessments at the start and immediately after the 12-week period. These assessments measure physical outcomes like knee extensor strength, grip strength, walking capacity, body mass index, weight, fat-free mass, fat mass, and body water. Mental health will also be evaluated to understand the psychological impact of the exercise program. The total participation time covers the 12-week exercise intervention and the corresponding assessments to monitor changes in health and wellbeing.

CONDITIONS

Brief Title

Exercise in Hereditary ATTR (ATTRv) Amyloidosis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • ATTRv Amyloidosis patients living in Portugal
  • Disease stage 1 or 2
  • No medical contraindication for exercising
  • Ability to provide informed consent
Not Eligible

You will not qualify if you...

  • Having undergone a liver transplant in the past 6 months

Research Team

C

Cláudia F. Barata, PhD

J

João L. Viana, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here